CWM
TEVA icon

Centric Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Centric Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,000
Closed -$20K – 233
2020
Q4 		$20K Buy
+10,000
New +$95.8K 0.01% 197

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Centric Wealth Management's TEVA Position: Q2 2021 in Review

Centric Wealth Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2021, closing a stake of 250,040 shares — an estimated $2.88M sold.

Centric Wealth Management first reported a position in TEVA in Q2 2020 and held it in 3 quarters. The position peaked at $2.88M in Q1 2021. 440 funds tracked by Wall St. Rank hold TEVA as of Q2 2021.

  • Centric Wealth Management reported no remaining Teva Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Centric Wealth Management sold 250,040 Teva Pharmaceuticals shares in Q2 2021, an estimated $2.88M.
  • Centric Wealth Management first reported a position in Teva Pharmaceuticals in Q2 2020 and held it in 3 quarters.
  • Centric Wealth Management's Teva Pharmaceuticals position peaked at $2.88M in Q1 2021.
  • 440 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2021.

Based on Centric Wealth Management's 13F filing for Q2 2021, filed 21 Jul 2021.